Press release
Investigation announced for Investors who lost money with shares of Theratechnologies Inc. (NASDAQ: THTX) over potential Wrongdoing
An investigation on behalf of investors in Theratechnologies Inc. (NASDAQ: THTX) shares over potential wrongdoing.
Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Theratechnologies Inc. officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Canada based Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. Theratechnologies Inc. reported that its annual Total Revenue rose from $69.82 million in 2021 to $80.05 million in 2022, and that its Net Loss increased from $31.04 million in 2021 to$46.74 million in 2022.
On January 24, 2024, Theratechnologies issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company's supplemental Biologics License Application (sBLA) for the F8 formulation of tesamorelin." The press release stated that "[t]he questions outlined in the CRL are largely related to chemistry, manufacturing and controls (CMC) concerning the microbiology, assays, impurities and stability for both the lyophilized product and the final reconstituted drug product. In addition, the FDA requested further information to understand the potential impact of the proposed formulation on immunogenicity risk."
Shares of Theratechnologies Inc. (NASDAQ: THTX) declined from $2.58 per share on January 08, 2024, to as low as $1.4 per share on January 24, 2024.
Those who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors who lost money with shares of Theratechnologies Inc. (NASDAQ: THTX) over potential Wrongdoing here
News-ID: 3630520 • Views: …
More Releases from Shareholders Foundation, Inc.
Long-Term Investors in shares of Molina Healthcare, Inc. (NYSE: MOH) should cont …
An investigation on behalf of current long-term investors in shares of Molina Healthcare, Inc. (NYSE: MOH concerning potential breaches of fiduciary duties by certain directors and officers of Molina Healthcare, Inc. was announced.
Investors who are current long term investors in Molina Healthcare, Inc. (NYSE: MOH) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law…
Cepton, Inc. (formerly NASDAQ: CPTN) Investor Alert: Investigation of potential …
An investigation on behalf of investors in shares of Cepton, Inc. (formerly NASDAQ: CPTN) concerning potential breaches of fiduciary duties by certain directors and officers was announced.
Investors who are current long term investors in Cepton, Inc. (formerly NASDAQ: CPTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for investors in formerly NASDAQ:…
Investigation announced for long term investors in shares of Spirit Aviation Hol …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Spirit Aviation Holdings, Inc.
Investors who are current long term investors in Spirit Aviation Holdings, Inc. (OTC: FLYYQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in OTC: FLYYQ stocks follows a…
ALERT: Lawsuit filed for Investors who lost money with shares of Bath & Body Wor …
An investor, who purchased shares of Bath & Body Works, Inc. (NYSE: BBWI), filed a lawsuit over alleged violations of Federal Securities Laws by Bath & Body Works, Inc.
Investors who purchased shares of Bath & Body Works, Inc. (NYSE: BBWI) have certain options and for certain investors are short and strict deadlines running. Deadline: March 16, 2026. NYSE: BBWI investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call…
More Releases for Theratechnologies
HIV-Associated Lipodystrophy Treatment Market Is Booming Worldwide 2024-2031 | T …
A new study titled HIV-Associated Lipodystrophy Treatment Market 2024, published by the Coherent Market Insights, offers information on regional and global markets that is expected to increase in value between 2024 and 2031. The extensive research offers important visions into the market's shifting dynamics, value chain analysis, well-known investment hotspots, competitive scenarios, regional landscape, and major segments. It also offers a whole analysis of the controls and restraints for the…
Lipodystrophy Industry to Witness Massive Growth (2024-2031) | Theratechnologies …
DataM Intelligence has published a new research report on "Lipodystrophy Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/lipodystrophy-market
The…
Investors who lost money with shares of Theratechnologies Inc. (NASDAQ: THTX) sh …
An investigation was announced over potential securities laws violations by Theratechnologies Inc. in connection with certain financial statements.
Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially false and…
Investigation announced for Investors in Theratechnologies Inc. (NASDAQ: THTX) s …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Theratechnologies Inc.
Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Theratechnologies officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
Canada based Theratechnologies…
Investigation announced for Investors who lost Money in Theratechnologies Inc. ( …
An investigation was announced for investors of Theratechnologies Inc. (NASDAQ: THTX) shares over potential securities laws violations by Theratechnologies Inc.
Investors who purchased shares of Theratechnologies Inc. (NASDAQ: THTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Theratechnologies Inc. regarding its business, its prospects and its operations were materially…
HIV Associated Lipodystrophy Syndrome Market | Alfa Wassermann S.P.A, Amylin Pha …
Global HIV Associated Lipodystrophy Syndrome Market: Overview
Human Immuno-deficiency Virus (HIV) presents itself as a complex mix of symptoms, which are related to severe immune compromise. Lipodystrophy is a condition, commonly associated with HIV patients globally, wherein there is a considerable loss of subcutaneous fat through the body. The increasing prevalence of lipodystrophy is the foremost factor driving the global market for HIV associated lipodystrophy syndrome. Continuous clinical advancements are…
